Long non-coding RNA PVT1 and cancer

Biochem Biophys Res Commun. 2016 Feb 26;471(1):10-4. doi: 10.1016/j.bbrc.2015.12.101. Epub 2016 Feb 3.

Abstract

Genome-wide sequencing technologies have led to the identification of many non-coding RNAs and revealed an important role for these molecules in cancer. Although there have been many studies on the role of short non-coding RNAs in cancer, much work remains to characterize the functions of long non-coding RNAs. PVT1, a long non-coding RNA encoded by the human PVT1 gene, is located in the well-known cancer-related region 8q24, also known as the 8q24 'gene desert.' PVT1 has three main molecular mechanisms of action: participating in DNA rearrangements, encoding microRNAs, and interacting with MYC. Studies on the association between PVT1 and cancer have shown that PVT1 is a potential oncogene in a variety of cancer types. However, the underlying molecular mechanisms of PVT1 in cancer remain unknown. Further studies of PVT1 will be required to test the utility of this molecule as a target for cancer diagnosis and therapy, and they should also increase our understanding of the role of long non-coding RNAs in tumorigenesis.

Keywords: Cancer; Long non-coding RNAs; PVT1; Tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics*
  • Carcinogenesis / genetics*
  • Genetic Markers / genetics
  • Humans
  • Models, Genetic*
  • Neoplasms / genetics*
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • Genetic Markers
  • PVT1 long-non-coding RNA, human
  • RNA, Long Noncoding